Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS) — Stock Score Summary

Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS) has a MoatMap StockRank of 92/100 based on Quality (62/100), Value (70/100), and Momentum (48/100) factor scores. The current signal is STRONG BUY. Zhejiang Hisun is a domestic Chinese pharmaceutical firm with some CDMO capabilities, but it lacks the global regulatory validation and high-end biologics capacity of tier-1 global CDMOs.

Zhejiang Hisun Pharmaceutical Co., Ltd. manufactures active pharmaceutical ingredients (APIs), generic formulations, and innovative biopharmaceuticals. The company maintains a strong competitive position through its extensive global regulatory certifications (FDA, CEP) and its advanced chemical synthesis capabilities. It is a leading, vertically integrated pharmaceutical exporter with a growing focus on high-margin biosimilars and oncology drugs.

Key Financial Metrics

Price$1.43
Market Cap$1.8B
P/E (TTM)16.20
P/E (Forward)26.27
Price/Book1.26
Return on Equity7.9%
Return on Invested Capital9.9%
Debt/Equity24.18
Gross Margin45.8%
Operating Margin15.5%
Revenue Growth-9.2%
Dividend Yield1.9%
Free Cash Flow$52M

Zhejiang Hisun Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Zhejiang Hisun Pharmaceutical Co., Ltd.’s (600267.SS) StockRank?
MoatMap’s StockRank for Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS) is 92/100, with a Strong Buy signal. It is a composite of Quality (62), Value (70), and Momentum (48) factor ranks across MoatMap’s 19,000+ stock universe.
Does Zhejiang Hisun Pharmaceutical Co., Ltd. have an economic moat?
Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS) has a Quality factor score of 62/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Zhejiang Hisun Pharmaceutical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS) is Strong Buy, based on a StockRank of 92/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Zhejiang Hisun Pharmaceutical Co., Ltd. in?
Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks600267.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock